Pterygium
78
1
2
44
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
2.6%
2 terminated out of 78 trials
95.7%
+9.1% vs benchmark
24%
19 trials in Phase 3/4
14%
6 of 44 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 44 completed trials
Clinical Trials (78)
Outcomes From Hyperbaric Oxygen (HBO2) Treatment for Emerging Indications
The Use of Lidocaine Gel Versus Subconjunctival Xylocaine Injection in Pterygium Excision
Comparing Two Surgical Methods to Prevent Pterygium Regrowth
Comparison Of Keratometric Readings Pre and Post Pterygium Excision With Conjunctival Autograft Transplantation
A Clinical Trial on Safety and Efficacy of CBT-001 in Patients With Pterygium
CsA vs MMC for Preventing Pterygium Recurrence
Clinical Outcomes of Sutured Versus Sutureless Conjunctival Autograft in Primary Pterygium Excision
RMP-A03 Ocular Suspension in Patients With Pterygium
Comparison of Recurrence Between Mini-SLET and Limbal-Conjunctival Autograft Techniques in Primary Pterygium
Platelet-rich Fibrin(PRF) Membrane in Ophthalmic Diseases
Comparison Between Topical Mitomycin C and Cyclosporine
Expression of CD44, PCNA and E-cadherin in Pterygium Tissue
Preoperative Bevacizumab Injection in Primary Pterygium in Tunisian Patients
Dextenza in Pterygium Surgery
Efficacy of Autologous Fibrin Glue in Pterygium
Manifestations of Ocular Irritation Following Pterygium Excision With Sutures Fixed Conjunctival Autograft
Corneal Topographic Changes After Pterygium Surgery
Subconjunctival Injection of Triamcinolone Acetonide and Limited Peritomy During Pterygium Excision
Brimonidine Tartrate for Pterygium Surgery
Molecular Taxonomy of Surgically-harvested Ocular Tissues Defined by Single-cell Transcriptomics